News

October 18, 2007 - Toshiba America Medical Systems Inc. is showcasing its suite of workflow and storage enhancements for ...

Home October 17, 2007
Home
News

October 18, 2007 - At TCT 2007, Philips Medical Systems is presenting two live interventional cases with the University ...

Home October 17, 2007
Home
News

October 18, 2007 - At TCT 2007, Radi Medical Systems Inc. focuses on the Femostop HD Femoral Compression System, that with the addition of a hemostatic dressing, promotes dual-action hemostasis, reportedly reducing the need for stocking multiple hemostasis products.

Home October 17, 2007
Home
News

October 18, 2007 - Cordis Corp. will present clinical data backing the CYPHER Sirolimus-eluting coronary stent at the ...

Home October 17, 2007
Home
News

October 18, 2007 - Abbott announced that trial results for ABSORB, the world’s first clinical trial evaluating the safety and performance of a fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease, are positive.

Home October 17, 2007
Home
Feature | Cristen C. Bolan

Ever since the BASKET-LATE study came out suggesting an increase in the rate of death and myocardial infarction in ...

Home October 17, 2007
Home
News

October 18, 2007 - Possis Medical Inc. featured the newest and the most important advancements in its "Complete Solution for Thrombus" at TCT 2007, including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.

Home October 17, 2007
Home
News

October 18, 2007 - Vascular Solution Inc. spotlights its Guardian hemostasis valve and Gopher Support Catheter at TCT ...

Home October 17, 2007
Home
News

October 17, 2007 - After a three-week trial, a jury rendered a verdict of "willful" patent infringement in a dispute filed against CHF Technologies, Inc., d/b/a BioVentrix, after Chase Medical sued BioVentrix alleging its Blue Egg Sizer, a hollow, blue silicone device used to guide surgeons in surgically resizing the heart, infringed patents held by Chase.

Home October 16, 2007
Home
Technology

The FDA gave ZOLL Medical Corp., a manufacturer of resuscitation devices and related software solutions, clearance to market and sell the ZOLL AED Pro with See-Thru CPR technology, which is designed to help minimize interruptions in CPR. ZOLL aims to comply with a key recommendation of the American Heart Association’s Guidelines for Advanced Cardiac Life Support.

Home October 16, 2007
Home
News

October 17, 2007 — The first trial to test whether medicated, drug-eluting (dispensing), stents can benefit patients who ...

Home October 16, 2007
Home
Technology

Building on the foundation of GE Healthcare’s CT platform, the LightSpeed VCT XT is reportedly capable of capturing ...

Home October 16, 2007
Home
News

October 17, 2007 – Siemens Medical Solutions today announced that it recently received FDA 510(k) clearance for a 1.5 ...

Home October 16, 2007
Home
Technology

The KODAK DIRECTVIEW Classic and Elite Computed Radiography Systems are compact, floor standing, single-cassette CR ...

Home October 16, 2007
Home
News

October 17, 2007 - Compared to bare metal stents, in patients with acute myocardial infarction, sirolimus-eluting stent ...

Home October 16, 2007
Home
Subscribe Now